Preclinical Evidence for Targeting PI3K/mTOR Signaling with Dual-Inhibitors as a Therapeutic Strategy against Cutaneous T-Cell Lymphoma

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Preclinical Evidence for Targeting PI3K/mTOR Signaling with Dual-Inhibitors as a Therapeutic Strategy against Cutaneous T-Cell Lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds